dacarbazine has been researched along with treosulfan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA | 1 |
| Hupert, M; Linz, U; Santiago-Schübel, B; Stab, J; Wagner, S; Wien, S | 1 |
1 trial(s) available for dacarbazine and treosulfan
| Article | Year |
|---|---|
A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Thrombocytopenia; Uveal Neoplasms | 2006 |
2 other study(ies) available for dacarbazine and treosulfan
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Transport of treosulfan and temozolomide across an in-vitro blood-brain barrier model.
Topics: Animals; Antineoplastic Agents, Alkylating; Biological Transport; Blood-Brain Barrier; Busulfan; Capillaries; Cells, Cultured; Dacarbazine; Endothelial Cells; Gray Matter; Swine; Temozolomide | 2015 |